feed,title,long_url,short_url
MarketWatch,Kinnate Biopharma stock price target cut to $44 from $53 at Wedbush,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=KNTE&siteid=rss,https://on.mktw.net/3HLXVkm
